Tehran University of Medical Sciences

Science Communicator Platform

Share By
Bi-Allelic Tpp1 Variants in Neuronal Ceroid Lipofuscinosis 2: Clinical Findings From an Iranian Cohort of 20 Patients, Founder Effect, and in Silico Analyses Publisher Pubmed



Biglari S ; Rezaei H ; Asadollahzadeh E ; Nikuei P ; Sahraian MA ; Sohanforooshan Moghaddam A ; Vahidnezhad H ; Youssefian L ; Galehdari H ; Seifi T ; Chamanrou N ; Heydaran S ; Parvas S ; Shariati G Show All Authors
Authors
  1. Biglari S
  2. Rezaei H
  3. Asadollahzadeh E
  4. Nikuei P
  5. Sahraian MA
  6. Sohanforooshan Moghaddam A
  7. Vahidnezhad H
  8. Youssefian L
  9. Galehdari H
  10. Seifi T
  11. Chamanrou N
  12. Heydaran S
  13. Parvas S
  14. Shariati G
  15. Saberi A
  16. Hamid M
  17. Zareei T
  18. Tabasi S
  19. Ranjbar S
  20. Khademi G
  21. Golmakani H
  22. Hashemi N
  23. Akhavan H
  24. Naseri M
  25. Donyadideh N
  26. Barkhordari E
  27. Beiraghi Toosi M
  28. Arabi S
  29. Heidari N
  30. Eghbal F
  31. Badpar H
  32. Saeidinia A
  33. Imannezhad S
  34. Bagheri S
  35. Lotfi M
  36. Mirsadraee M
  37. Loghmani T
  38. Darabi A
  39. Derafshi R
  40. Behmadi M
  41. Boskabadi A
  42. Akhondian S
  43. Eshraghi P
  44. Hosseini M
  45. Farhat A
  46. Ghane Sharbaf F
  47. Norooziasl S
  48. Ghaemi N
  49. Ahangari N
  50. Etemadifar M
  51. Moosavian T
  52. Shervin Badv R
  53. Houlden H
  54. Sarraf P
  55. Haghighatzadeh M
  56. Heidari M
  57. Ghayoor Karimiani E

Source: Human Genetics Published:2026


Abstract

Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) is a rare neurodegenerative disorder. It exhibits an autosomal recessive inheritance pattern and is attributable to pathogenic variants in the TPP1 gene. This study sought to identify and characterize TPP1 variants in eighteen Iranian consanguineous families affected by CLN2 disease. A developmental history, brain imaging, and neurological evaluation were conducted. Exome sequencing (ES) was conducted on the probands' DNA. ACMG criteria were used to evaluate pathogenicity, as well as several in silico prediction techniques, protein stability algorithms, and homozygosity mapping. Three-dimensional protein modeling was used to assess structural effects. Shared haplotypes have been determined to assess possible founder alleles and the time to the most recent common ancestor (MRCA). We found twelve different TPP1 bi-allelic variants, six of which had never been reported before, two of which were only listed in ClinVar, and four of which were known to be pathogenic alleles. It contained four various types of variants: missense (33%), nonsense (25%), frameshift (25%), and splice-site (17%). The majority of the variants were found within the peptidase S53 domain. All new alleles were found in the rare-plus-high-CADD range, which is higher than the gene-specific mutation significance cutoff (MSC). The recurrence of c.729C > G (p.Phe243Leu) in several families, along with a common ~ 2.86 Mb homozygous haplotype and an estimated most recent common ancestor (MRCA) of ~ 16.7 generations (~ 450 years), strongly indicates a founder effect. Psychomotor regression was universal in clinical settings, seizures usually started between the ages of 3 and 5, and 40% of patients died before the age of 10. No affected patients received enzyme replacement therapy due to financial constraints. This study represents the most extensive Iranian series of CLN2 to date, broadens the TPP1 mutational spectrum with six novel alleles, and reveals a significant founder effect. The results improve genotype–phenotype correlations and show how important it is to do carrier screening that is specific to each population and to make enzyme replacement therapy available quickly in regions with limited funding. ES proved critical for accurate CLN2 diagnosis, precise genetic counseling, and revealing gaps in the availability of broad treatment for rare disorders. © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2026.
Related Docs
View other Related Docs
1. Pathogenic Significance of Scn1a Splicing Variants Causing Dravet Syndrome: Improving Diagnosis With Targeted Sequencing for Variants by in Silico Analysis, Clinical Neurology and Neurosurgery (2018)
2. Exome Sequencing Identifies a Novel Pathogenic Clcn1 Mutation in an Iranian Family With Myotonia Congenita: A Case Report, Human Gene (2022)
3. Mutational Screening Through Comprehensive Bioinformatics Analysis to Detect Novel Germline Mutations in the Apc Gene in Patients With Familial Adenomatous Polyposis (Fap), Journal of Clinical Laboratory Analysis (2021)
Experts (# of related papers)
View all Related Experts
Reza Shervin Badv (3)
Ali Reza Tavasoli (3)
Other Related Docs
4. A Novel Pathogenic Variant in the Fzd6 Gene Causes Recessive Nail Dysplasia in a Large Iranian Kindred, Journal of Dermatological Science (2017)
5. Germline Variants in Patients From the Iranian Hereditary Colorectal Cancer Registry, Cancer Cell International (2025)
6. Clinical and Molecular Assessment of Iranian Families With Severe Congenital Neutropenia, Identification of Hyou1 and Shoc2 As Potential Novel Gene Defects, Iranian Journal of Allergy# Asthma and Immunology (2022)
7. Identification of Eleven Different Mutations Including Six Novel, in the Arylsulfatase B Gene in Iranian Patients With Mucopolysaccharidosis Type Vi, Molecular Biology Reports (2019)
8. Targeted Next Generation Sequencing Identified a Novel Mutation in Myo7a Causing Usher Syndrome Type 1 in an Iranian Consanguineous Pedigree, International Journal of Pediatric Otorhinolaryngology (2018)
9. Dna Repair-Related Heritable Photosensitivity Syndromes: Mutation Landscape in a Multiethnic Cohort of 17 Multigenerational Families With High Degree of Consanguinity, DNA Repair (2024)
10. Genotype-Phenotype Correlation and Description of Two Novel Mutations in Iranian Patients With Glycogen Storage Disease 1B (Gsd1b), Orphanet Journal of Rare Diseases (2020)
11. A Novel Deletion Variant in Cln3 With Highly Variable Expressivity Is Responsible for Juvenile Neuronal Ceroid Lipofuscinoses, Acta Neurologica Belgica (2021)
12. Rpe65 and Retinal Dystrophy: Report of New and Recurrent Mutations, Journal of Gene Medicine (2020)
13. Hypotrichosis With Juvenile Macular Dystrophy: Combination of Whole-Genome Sequencing and Genome-Wide Homozygosity Mapping Identifies a Large Deletion in Cdh3 Initially Undetected by Whole-Exome Sequencing—A Lesson From Next-Generation Sequencing, Molecular Genetics and Genomic Medicine (2019)
14. A Comprehensive Study of Mutation and Phenotypic Heterogeneity of Childhood Mitochondrial Leukodystrophies, Brain and Development (2024)
15. Spinal Muscular Atrophy With Progressive Myoclonic Epilepsy (Sma-Pme): Three New Cases and Review of the Mutational Spectrum, Italian Journal of Pediatrics (2023)
16. A Novel Pathogenic Variant in the Lrtomt Gene Causes Autosomal Recessive Non-Syndromic Hearing Loss in an Iranian Family, BMC Medical Genetics (2020)
17. The Genetic Basis of Early-Onset Hereditary Ataxia in Iran: Results of a National Registry of a Heterogeneous Population, Human Genomics (2024)
18. Molecular Genetic Study of Glutaric Aciduria, Type I: Identification of a Novel Mutation, Journal of Cellular Biochemistry (2019)
19. In Silico Analysis of Novel Mutations in Maple Syrup Urine Disease Patients From Iran, Metabolic Brain Disease (2017)
20. Novel Pyrroline-5-Carboxylate Reductase 2 (Pycr2) Mutation in an Iranian Patient With Hypomyelinating Leukodystrophy: Findings of Molecular and in Silico Investigations, Egyptian Journal of Medical Human Genetics (2023)